Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

50 brain injury patients help doctors rethink ICU monitoring

NCT ID NCT07285733

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked back at data from 50 patients with severe brain injuries (from trauma or bleeding) who were treated in the ICU. Researchers analyzed brain blood flow, oxygen levels, and scans to understand how treatments affect the brain and body. The goal is to develop more personalized care for future patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

50 people

The number who actually took part.

Started

Feb 2010

Finished

Apr 2014

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Primarily admitted to the Antwerp University Hospital

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

This study is based on the 50 patients recruited for the original study. For TBI: Inclusion Criteria: * male or female patients aged 18 to 70 years, inclusive * sustained head injury within the previous 24 hours * TBI diagnosed by history, clinical examination with a GCS of 12 or less * evidence of TBI confirmed by abnormalities on CT scan * clinical indication to monitor ICP * informed consent is obtained from the patient or from a legally acceptable representative Exclusion Criteria: * life expectancy of less than 24 hours as determined by the investigator * any spinal cord injury * coma suspected to be primarily due to causes other than head injury, such as drug or alcohol overdose * clinically significant or active gastro-intestinal, renal, hepatic, endocrine or CNS disease or chronic condition (e.g.psychiatric disorder) that can be ascertained at the time of admission and could affect functional outcome * respiratory/hemodynamic instability, refractory to treatment and precluding transport for neuroimaging studies * pregnancy * special exclusion criteria for MRI, such as non-removable metals, artificial joints, electronic devices (pacemaker, pumps etc.) * informed consent is obtained from a legally acceptable representative, prior to any study related activity For aneurysmal subarachnoid hemorrhage: Inclusion Criteria: * male or female patients aged 18 to 70 years, inclusive * ruptured aneurysm, demonstrated by CT angiography or DSA * onset of SAH clinical symptoms within the preceding 72 hours * World Federation of Neurosurgery (WFNS) grade III-IV and grade V patients, who improve within 24 hours after ventriculostomy * indication for ICP monitoring or CSF drainage * informed consent is obtained from the patient or a legally acceptable representative Exclusion Criteria: * non-aneurysmal subarachnoid hemorrhage * admission in a clinical state with extremely poor prognosis (e.g. wide, non-reactive pupils for more than 1 hour) * significant coagulation disturbances (thrombocytes \< 80 per mL, partial thromboplastin time \> 45 sec, INR \> 1.5) * cytostatic therapy in patients with malignant disease * pregnancy * special exclusion criteria for MRI, such as non-removable metals, artificial joints, electronic devices (pacemaker, pumps etc.) * respiratory and/or hemodynamic instability precluding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Subarachnoid aneurysm hemorrhage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.